Neuroprotective therapies: Preclinical reproducibility is only part of the problem
Michael Tymianski · Science Translational Medicine · 2015
Among the many unknowns in the translational path to developing drugs for acute stroke, addressing the reproducibility of preclinical data is only one piece of a multifaceted and incomplete puzzle (Llovera et al., this issue).